| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 120.988 | 78 |
| GSM780708 | Untreated after 4 days (C2_1) | 92.5862 | 74 |
| GSM780709 | Untreated after 4 days (C3_1) | 101.007 | 75 |
| GSM780719 | Untreated after 4 days (C1_2) | 139.372 | 80 |
| GSM780720 | Untreated after 4 days (C2_2) | 106.711 | 76 |
| GSM780721 | Untreated after 4 days (C3_2) | 129.014 | 79 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 87.0737 | 73 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 123.117 | 78 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 118.892 | 78 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 93.7005 | 74 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 108.126 | 76 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 119.145 | 78 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 110.536 | 77 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 103.898 | 76 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 107.201 | 76 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 118.057 | 77 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 123.974 | 78 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 113.066 | 77 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 132.883 | 79 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 112.941 | 77 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 113.851 | 77 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 130.51 | 79 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 122.752 | 78 |